Inside Industry
Abstract
The following topics are under this section:
Preclinical data demonstrates favourable safety profile of novel anti-HER3 antibody
Phase III clinical trial reveals positive results for cancer immunotherapy in treating the most common form of liver cancer
Strategic partnership to bring hope to patients with fibrotic and inflammatory diseases
Hong Kong’s first Mononuclear Cell Bank attains AABB accreditation
Expanding reach of Biosimilar candidates in Taiwan and Hong Kong
Developing Novel Cancer Therapies with Greater Precision
Singapore-based MedTech Start-up raises US$ 4 million in funding
Asia’s HealthTech Momentum Remains Strong at US$ 5 billion in 2019
Emergex raises more than US$ 11 million in Series A Round
Korean-based biotechnology company seals exclusive sales agreement
